B Group Inc’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.2M Buy
80,000
+10,000
+14% +$150K 0.92% 14
2025
Q1
$1.13M Buy
70,000
+20,000
+40% +$323K 0.97% 13
2024
Q4
$1.16M Buy
+50,000
New +$1.16M 0.71% 10